sivelestat has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, A; Bando, M; Date, H; Ebina, M; Fukuoka, J; Gemma, A; Goto, Y; Hasegawa, Y; Hattori, N; Homma, S; Inase, N; Inoue, Y; Ishii, Y; Izumi, S; Johkoh, T; Kido, T; Kishaba, T; Kishi, K; Miyamoto, A; Mukae, H; Nakayama, T; Nishioka, Y; Ogura, T; Sakamoto, S; Sasaki, S; Suda, T; Sugino, K; Taguchi, Y; Takahashi, H; Takahashi, K; Taniguchi, H; Watanabe, K; Yokoyama, A; Yoshino, I | 1 |
| Hayashi, N; Matsumoto, S; Okamoto, H; Otsuka, T; Sakai, M; Takenami, T; Yoshino, K | 1 |
| Chinen, H; Hibi, T; Hisamatsu, T; Inoue, N; Iwao, Y; Kamada, N; Matsuoka, K; Morohoshi, Y; Ogata, H; Okamoto, S; Sato, T; Takaishi, H | 1 |
| Kozawa, S; Miyazawa, N; Nakamura, M; Ogura, T; Tagawa, A; Takahashi, H; Watanuki, Y | 1 |
| Aze, Y; Hagio, T; Kawabata, K; Matsumoto, S; Nakao, S; Ohno, H; Orita, S | 1 |
1 review(s) available for sivelestat and Disease Exacerbation
| Article | Year |
|---|---|
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Disease Progression; Drug Therapy, Combination; Evidence-Based Medicine; Glycine; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Indoles; Japan; Lung Neoplasms; Meta-Analysis as Topic; Practice Guidelines as Topic; Prognosis; Pyridones; Quality of Health Care; Sulfonamides; Survival Rate | 2018 |
4 other study(ies) available for sivelestat and Disease Exacerbation
| Article | Year |
|---|---|
[Anesthetic management of posterior lumbar spinal fusion in a patient suspected of having acute exacerbation of chronic interstitial pneumonia].
Topics: Acute-Phase Reaction; Aged; Airway Management; Anesthesia; Chronic Disease; Disease Progression; Emergency Medical Services; Female; Glycine; Humans; Lumbar Vertebrae; Lung Diseases, Interstitial; Perioperative Care; Postoperative Complications; Respiration Disorders; Spinal Fusion; Spinal Stenosis; Sulfonamides | 2014 |
Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis.
Topics: Adult; Animals; Biomarkers; Cells, Cultured; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Disease Progression; Female; Glycine; Humans; Intestinal Mucosa; Leukocyte Elastase; Male; Mice; Mice, Inbred C57BL; Serine Proteinase Inhibitors; Sulfonamides | 2006 |
[Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
Topics: Acute Disease; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Chronic Disease; Disease Progression; Female; Glycine; Humans; Leukocyte Elastase; Male; Middle Aged; Mucin-1; Mucins; Pulmonary Fibrosis; Pulmonary Surfactant-Associated Protein D; Respiratory Insufficiency; Serine Proteinase Inhibitors; Sulfonamides; Treatment Outcome | 2007 |
Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cricetinae; Disease Progression; Endotoxins; Glycine; Leukocyte Count; Leukocyte Elastase; Lung; Male; Mesocricetus; Neutrophils; Respiratory Distress Syndrome; Serine Proteinase Inhibitors; Sulfonamides | 2000 |